2024年 新着論文 4 生体機能学分野から論文が発表されました

Simplified drug efficacy evaluation system for vasopressin neurodegenerative disease using mouse disease-specific induced pluripotent stem cells

Peptides. 2024 Jan 10:171151. doi: 10.1016/j.peptides.2024.171151. Online ahead of print.

Authors

Tsutomu Miwata  1 Hidetaka Suga  2 Kazuki Mitsumoto  3 Jun Zhang  4 Yoshimasa Hamada  4 Mayu Sakakibara  1 Mika Soen  1 Hajime Ozaki  1 Tomoyoshi Asano  1 Takashi Miyata  1 Yohei Kawaguchi  1 Yoshinori Yasuda  1 Tomoko Kobayashi  1 Mariko Sugiyama  1 Takeshi Onoue  1 Daisuke Hagiwara  1 Shintaro Iwama  1 Seiichi Oyadomari  4 Hiroshi Arima  1

Affiliations

  • 1 Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • 2 Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: sugahide@med.nagoya-u.ac.jp.
  • 3 Department of Endocrinology and Diabetes, Gifu Prefectural Tajimi Hospital, Tajimi, Japan.
  • 4 Division of Molecular Biology, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.

Abstract

Familial neurohypophyseal diabetes insipidus (FNDI) is a degenerative disorder in which vasopressin-secreting neurons degenerate over time due to the production of mutant proteins. We have demonstrated therapeutic effects of chemical chaperones in an FNDI mouse model, but the complexity and length of this evaluation were problematic. In this study, we established disease-specific mouse induced pluripotent stem cells (iPSCs) from FNDI-model mice and differentiated vasopressin neurons that produced mutant proteins. Fluorescence immunostaining showed that chemical chaperones appeared to protect vasopressin neurons generated from iPSCs derived from FNDI model mice. Although KCL stimulation released vasopressin hormone from vasopressin neurons generated from FNDI-derived iPSCs, vasopressin hormone levels did not differ significantly between baseline and chaperone-added culture. Semi-quantification of vasopressin carrier protein and mutant protein volumes in vasopressin neurons confirmed that chaperones exerted a therapeutic effect. This research provides fundamental technology for creating in vitro disease models using human iPSCs and can be applied to therapeutic evaluation of various degenerative diseases that produce abnormal proteins.

Keywords: Familial neurohypophyseal diabetes insipidus; mouse disease-specific induced pluripotent stem cells; mutant neurophysin II; neurodegenerative disease; semi-quantification; vasopressin neurons.

Conflict of interest statement

Declaration of interests The authors declare no competing interests.